 |
|
|
Table 3: Standard Treatment Approaches for Infants and Children Younger Than 15 Years With
Germ Cell Tumors by Histology, Stage, and Primary Site
|
Histology
|
Primary Site
|
Stage
|
Treatment
|
| Mature teratoma |
All sites |
Localized |
Surgery + Observation |
| Immature teratoma |
All sites |
Localized |
Surgery + Observation |
| Malignant germ cell tumors |
Testicular |
Stage I |
Surgery + Observation |
| Stages II–IV* |
Surgery + PEB |
|
Ovarian |
Stage I |
Surgery + Observation |
| Stages II–IV |
Surgery + PEB |
| Extragonadal |
Stages I–II |
Surgery** + PEB |
| Stages III–IV* |
Surgery** + PEB |
|
*Patients ≥15 years with stage IV testicular tumors and all patients with stages III and IV extragonadal tumors treated with PEB have suboptimal outcome and should be considered for more intensive therapies.
|
|
**The role for surgery at diagnosis for extragonadal tumors is age- and site-dependent and must be individualized. Depending on the clinical setting, the
appropriate surgical approach may range from no surgery (e.g., mediastinal
primary tumor in a patient with a compromised airway and elevated tumor
markers), to biopsy, to primary resection. In some cases, an appropriate
strategy is biopsy at diagnosis followed by subsequent surgery in selected
patients who have residual masses following chemotherapy.
|
|
|
 |